Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

RAD51-IN-17 is an inhibitor of RAD51 recombinase.1 It inhibits DNA damage-induced RAD51 foci formation in MDA-MB-231 triple-negative breast cancer (TNBC) cells when used at a concentration of 10 µM. RAD51-IN-17 (10 µM) enhances irradiation-induced reductions in the proliferation of MDA-MB-231 cells.
WARNING This product is not for human or veterinary use.
1. Quinazolinone derivatives as inhibitors of homologous recombinase RAD51. Bioorg. Med. Chem. Lett. 27(14), 3096-3100. (2017).